SRPT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SRPTSarepta Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SRPTSarepta Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SRPT 9

ARWRArrowheadsupplier

BMRNBioMarinsupplier

—Catalentunlistedsupplier

—Brammer Bio MA, LLC, an affiliate of Thermo Fisher Scientific, Inc. ("Thermo")unlistedsupplier

5 more · SRPT chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

SRPTSarepta Therapeutics, Inc.

17.54▼−7.65%· post 17.18

Mkt cap$2.0BRevenue$381MQ3 FY26Revenue$2.2BFY25

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

SRPTSarepta Therapeutics, Inc.

LLYELI Lilly & Co

17.54▼−7.65%post 17.18

Price

1,371.32▼−3.29%post 1,363.77

$2.0B

Mkt cap

$1.2T

Q3 FY26$381M

Revenue

$24.4BQ3 FY26

FY25$2.2B

Revenue

$65.2BFY25

SRPT17.54▼−7.65%vsLLY1,371.32▼−3.29%ClosedNov 5 '26